Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Baudax Bio Announces Corporate Update; Co. Says Phase 1/2a Clinical Study Of TI-168 In Hemophilia A with FVIII Inhibitors Projected To Begin In Q1 2024

Author: Benzinga Newsdesk | October 18, 2023 08:12am

Posted In: BXRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist